Skip to main content
Donate

Researchers

FAST E-Journal

FAST Dart E-Journal Logo

Welcome to FAST DART, a free online archive and e-journal dedicated to advancing Angelman syndrome research. Here, researchers can share unpublished data, preprints, negative or null results, biotechniques in development, and literature reviews to foster collaboration and innovation in the AS community. By openly sharing results and insights, even those not traditionally published, we aim to prevent duplication, refine approaches, and accelerate the path toward new therapies. We invite you to contribute your work and help build a transparent and dynamic resource for all working to better understand and treat Angelman syndrome.

About this E-Journal

Submit Your Data

Disclaimers

Articles by Type

Reviews

  • coming soon

Biotechniques

  • coming soon

Original Papers

  • coming soon

Edwin Weeber, PhD

Editor-in-Chief

Ed has a long history not just with Angelman syndrome, but with FAST. To start with, he led pioneering initiatives aimed at ameliorating the symptoms in the Angelman syndrome mouse model. Through a multifaceted approach encompassing genetic interventions, protein supplementation strategies, and gene therapy techniques, his groundbreaking work shed light on the underlying mechanisms of the disorder and the potential for therapeutic intervention. In addition, he helmed the first AS consortium of scientists from different specialties and academic laboratories to collaborate and focus on discovering potential therapies for AS. This collaborative effort was dedicated to the development of promising therapeutic avenues.

He will now extend this dedication to scientific advancement in his role as Editor-in-Chief of FAST’s DART e-journal, providing strategic leadership to further its mission of disseminating high-quality research in Angelman syndrome.

Meet Edwin Weeber, PhD

FAST Angelman Syndrome News

Disclaimer

This website contains information for a broad audience and may include information on current and upcoming programs that are not yet approved or accessible The information provided is for general informational purposes only and is not intended as medical advice, diagnosis, or treatment. While FAST strives to provide accurate and up-to-date information, the content on this site may not always reflect the most current research or clinical guidelines. The inclusion of clinical trial information, treatments or specific healthcare providers does not imply endorsement, recommendation or guarantee of safety, efficacy, or availability. Reliance on any information provided by this website is solely at your own risk. FAST disclaims any liability for any errors or omissions in the information provided or for any decisions made based on this information. For personalized medical advice or specific health concerns including participation in any clinical trial, please consult a qualified healthcare professional.